Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Current Deferred Revenue (2016 - 2019)

Historic Current Deferred Revenue for CorMedix (CRMD) over the last 5 years, with Q4 2019 value amounting to $2206.0.

  • CorMedix's Current Deferred Revenue fell 7999.82% to $2206.0 in Q4 2019 from the same period last year, while for Dec 2019 it was $2206.0, marking a year-over-year decrease of 7999.82%. This contributed to the annual value of $2206.0 for FY2019, which is 7999.82% down from last year.
  • Per CorMedix's latest filing, its Current Deferred Revenue stood at $2206.0 for Q4 2019, which was down 7999.82% from $4411.0 recorded in Q3 2019.
  • CorMedix's 5-year Current Deferred Revenue high stood at $132611.0 for Q2 2016, and its period low was $2206.0 during Q4 2019.
  • For the 5-year period, CorMedix's Current Deferred Revenue averaged around $59727.4, with its median value being $52144.5 (2017).
  • Its Current Deferred Revenue has fluctuated over the past 5 years, first tumbled by 1516.75% in 2017, then plummeted by 8752.43% in 2018.
  • Over the past 5 years, CorMedix's Current Deferred Revenue (Quarter) stood at $130409.0 in 2015, then decreased by 20.09% to $104210.0 in 2016, then fell by 15.17% to $88404.0 in 2017, then tumbled by 87.52% to $11029.0 in 2018, then crashed by 80.0% to $2206.0 in 2019.
  • Its last three reported values are $2206.0 in Q4 2019, $4411.0 for Q3 2019, and $6618.0 during Q2 2019.